EUVIMEDEUVIMED entdecken
Crossref

microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia

Lingyue Xu, Ailing Wang, Hongzai Guan iD

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Lingyue Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, MicroRNAs, Biomarkers, Tumor, rab GTP-Binding Proteins. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMicroRNAsBiomarkers, Tumorrab GTP-Binding ProteinsHumansMaleFemaleMiddle AgedAdultPrognosisAgedCase-Control StudiesYoung Adult

Stichwörter der Autor:innen

ELISARab10acute myeloid leukemiamicroRNA-106b-5pqRT-PCR

Substanzen

MicroRNAsMIRN106 microRNA, humanRab10 protein, humanBiomarkers, Tumorrab GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Shibei District People's Hospital, Qingdao, China.

ORCID-Profile: Hongzai Guan

Zitieren

APA

Xu, L., Wang, A., & Guan, H. (2024). microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0191

Vancouver

Xu L, Wang A, Guan H. microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0191

BibTeX
@article{Xu2024,
  author = {Xu, Lingyue and Wang, Ailing and Guan, Hongzai},
  title = {microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0191}
}
Kostenlos starten →